Vimta Labs Ltd.

NSE: VIMTALABS | BSE: 524394 | ISIN: INE579C01029 |Industry: Healthcare Services
|Expensive Star
169.10 -0.05 (-0.03%)
NSE Jan 22, 2021 15:31 PM
Volume: 25,378

Vimta Labs Ltd.    
18 Dec 2017
Rudra Shares and Stock Brokers Ltd
Clinical research and testing - Major Revenue Contributor - Provide stability Company has presence in pre-clinical testing having an strong analytical skills and provides these services to pharma, bio-tech, animal health, Bio-similar clients and medical device companies. Analytical division contribute around 45% of revenues which provides better stability to the overall business. In clinical research and testing India is rapidly gaining market share over China due to better quality and technology protection laws. Also the innovators are now outsourcing these operations to low cost countries due to better cost economics. Due to these factors industry as a whole is expected to grow at a good pace which would be...
Vimta Labs Ltd. is trading below it's 30 day SMA of 173.4
More from Vimta Labs Ltd.